ster

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Viriom China Wins Award at 2018 Zhongguancun International Frontier Science and Technology Innovation Competition
Torrey Pines Investment’s i2020 Accelerator to Advance Snap Bio’s Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases
Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry
Read All Our News >

Pharma News

US approves first treatment for post-partum depression
Merck, Pfizer pull the plug on ovarian cancer trial
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer
Read All Pharma News >

New Products &Services

Therapeutical Diversity library
Cardiovascular library
CNS MPO library
RNA Trinucleotide mimetics